Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results>CSPC PHARMA Annual NP RMB4.328B, Down 26.3%; Final Div. Cut to HK10 Cents
Recommend 20 Positive 24 Negative 15 |
||||
|
||||
|
CSPC PHARMA (01093.HK) has announced its annual results for the year ended December 2024. The company's turnover declined by 7.8% YoY to RMB29.009 billion, while its net profit amounted to RMB4.328 billion, down 26.3% YoY, with EPS standing at RMB36.87 cents. Its GPM also edged down by 0.5 ppts to 70.0%. A final dividend of HK10 cents was declared, compared to HK14 cents in the corresponding period of the previous year. Together with the interim dividend, the full-year dividend reached HK26 cents, compared to HK28 cents for the entire previous year. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
